Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Cidara Therapeutics Stock Forecast NASDAQ:CDTX
Price Target and Analyst Ratings
Historical Ratings
| Date | Upside / Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 2022-05-12 | 1204.35% | HC Wainwright & Co. | $7.50 $6.00 | Maintains | Buy |
| 2021-09-22 | 1639.13% | Aegis Capital | $9.00 $8.00 | Maintains | Buy |
| 2021-09-22 | - | WBB Securities | - | Upgrades | Buy Strong Buy |
| 2021-03-04 | 1856.52% | Aegis Capital | $9.00 | Initiates Coverage On | Buy |
| 2020-08-26 | 986.96% | Citigroup | $6.00 $5.00 | Maintains | Buy |
| 2020-03-05 | 1204.35% | Needham | $10.00 $6.00 | Maintains | Buy |
| 2019-12-04 | 1258.7% | WBB Securities | $6.25 | Upgrades | Speculative Buy Buy |
| 2019-09-04 | - | Wedbush | - | Upgrades | Neutral Outperform |
| 2019-06-06 | 1204.35% | Oppenheimer | $6.00 | Initiates Coverage On | Outperform |
| 2019-05-17 | 334.78% | Wedbush | $7.00 $2.00 | Downgrades | Outperform Neutral |
CDTX Stock Trend
The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.41 is broken, it will firstly indicate a stronger fall rate.
Given the current short-term trend, the stock is expected to fall -17.83% during the next 3 months and, with a 90% probability hold a price between $0.34 and $0.74 at the end of this 3-month period.
Data
| Date | Bottom | Mid | Top |
|---|---|---|---|
| 2022-05-25 | $0.41 | $0.65 | $0.90 |
| 2022-05-26 | $0.40 | $0.65 | $0.90 |
| 2022-05-27 | $0.40 | $0.65 | $0.89 |
| 2022-05-31 | $0.40 | $0.64 | $0.89 |
| 2022-06-01 | $0.39 | $0.64 | $0.89 |
| 2022-06-02 | $0.39 | $0.64 | $0.88 |
| 2022-06-03 | $0.39 | $0.63 | $0.88 |
| 2022-06-06 | $0.38 | $0.63 | $0.88 |
| 2022-06-07 | $0.38 | $0.63 | $0.87 |
| 2022-06-08 | $0.38 | $0.62 | $0.87 |
| 2022-06-09 | $0.37 | $0.62 | $0.87 |
| 2022-06-10 | $0.37 | $0.62 | $0.86 |
| 2022-06-13 | $0.37 | $0.61 | $0.86 |
| 2022-06-14 | $0.36 | $0.61 | $0.86 |
| 2022-06-15 | $0.36 | $0.61 | $0.85 |
| 2022-06-16 | $0.36 | $0.60 | $0.85 |
| 2022-06-17 | $0.35 | $0.60 | $0.85 |
| 2022-06-21 | $0.35 | $0.60 | $0.84 |
| 2022-06-22 | $0.35 | $0.59 | $0.84 |
| 2022-06-23 | $0.34 | $0.59 | $0.84 |
| 2022-06-24 | $0.34 | $0.59 | $0.83 |
| 2022-06-27 | $0.34 | $0.58 | $0.83 |
| 2022-06-28 | $0.33 | $0.58 | $0.83 |
| 2022-06-29 | $0.33 | $0.58 | $0.82 |
| 2022-06-30 | $0.33 | $0.58 | $0.82 |
| 2022-07-01 | $0.33 | $0.57 | $0.82 |
| 2022-07-05 | $0.32 | $0.57 | $0.82 |
| 2022-07-06 | $0.32 | $0.57 | $0.81 |
| 2022-07-07 | $0.32 | $0.56 | $0.81 |
| 2022-07-08 | $0.31 | $0.56 | $0.81 |
Cidara Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of various diseases. Its lead product candidate is CD101 IV, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of systemic Candida infections. The company also develops CD101 topical, a topical formulation of CD101 for the treatment of recurrent vul... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
